Clariant to launch eight new high-performing excipients at the CPHI Milan 2024
Clariant is launching high-performing pharmaceutical ingredients to support the evolution of safe and effective medicines
Clariant is launching high-performing pharmaceutical ingredients to support the evolution of safe and effective medicines
Grant funding from the Bill & Melinda Gates Foundation will support the rapid and efficient design and synthesis of novel small molecules
This facility underwent an inspection from 15th to 19th July 2024 and has been classified as Voluntary Action Indicated
The authorization of bortezomib will enhance the company’s ability to deliver advanced cancer solutions in Southeast Asia
The observations are of procedural in nature and will be responded to within the stipulated time
He holds a Master’s in Management from the National University of Singapore
Lupin's Pithampur Unit-1 gets Form 483 from USFDA with 3 observations
A first-in-class muscarinic agonist for the treatment of schizophrenia in adults
Agreement enables access of EU-approved treatment for myotonia symptoms in non-dystrophic myotonic disorders to patients from Argentina and Colombia
Subscribe To Our Newsletter & Stay Updated